Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode 8

December 19, 2024 • 00:24:20

Bringing the Consumer Experience to Clinical Research

In this episode of Power to the Patients, Srinivas Pai sits down with Katie Baca-Motes, Co-Founder at Scripps Research Digital Trial Center, to discuss...

Episode 14

February 25, 2025 • 00:45:01

Next-Gen Treatments for Anxiety and Depression Disorders

In this episode, Brandon sits down with Shawn Singh, CEO of Vistagen, to discuss a first-of-its-kind approach to treating mental health conditions. Vistagen is...

Episode 10

January 29, 2025 • 00:46:27

Harnessing Precision Medicine to Redefine Psychiatric Treatment

On this episode of Power to the Patients, we are joined by Amit Etkin, Founder & CEO of Alto Neuroscience and adjunct professor at...